Phenoxodiol

New Ovarian Cancer Drug Trial Under Way

... phenoxodiol could help women resistant to other medicines F...f a new drug, phenoxodiol. In previous studies, phenoxodiol has shown some success in helping traditional chem... to fight cancer cells. The Phase III study of phenoxodiol will take place at 30 sites in the United States, ...

Drug stabilizes cancer growth

...cancer in 7 out of 10 patients while causing minimal side effects. The drug phenoxodiol was given to patients with a variety of cancers that failed// standard chem...ansduction inhibitors, all designed to switch off certain cancer processes. phenoxodiol was discovered by Novogen Ltd., Marshall Edwards' Australian parent company...

Phenoxodiol in Medical Technology

A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol

OVATUREtrial.com Launched to Inform Patients with Recurrent Ovarian Cancer about the OVATURE Clinical Research Study NEW CANAAN, Conn., Aug. 30 /PRNewswire-FirstCall/ -- A new website has been launched to facilitate recruitment of patients to OVATURE (OVArian TUmor REsponse), a Ph...

First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial

...aughton said. In a prior Phase II clinical trial, phenoxodiol was tested in combination with either cisplatin or...py, were treated with phenoxodiol and cisplatin or phenoxodiol and paclitaxel, respectively. Of 21 patients in th...pe OVATURE in the search box). About phenoxodiol: phenoxodiol is being developed as a therapy for late- stage, c...

New Research Results Show That Investigational Drug Phenoxodiol Targets Cancer Protein, Causing Cancer Cell Death

...n the U.S. alone. In studies conducted thus far, phenoxodiol has exhibited an excellent safety profile, with fe...held May 9-11, help explain the mechanism by which phenoxodiol induces cancer cell death. This new research suppo...rre, Ph.D. at Purdue University, which showed that phenoxodiol interacts with the tumor-specific protein, tNOX, t...

Phenoxodiol in Biological Technology

New Report Just Published: World Prostate Cancer Therapeutics Market Report

...nt Prostate Cancer II-57 Antisoma Reveals Results from AS1404 Phase II Clinical Trial in HRPC II-57 Marshall Edwards Conducts Study on phenoxodiol in Prostate Cancer II-58 Combination of Provenge(R) and Taxotere(R) Offer Better Results for HRPC Patients II-58 Ambrilia Reveals Results ...

Marshall Edwards, Inc. to Present at BIO Investor Forum 2007

... Australia, is developing a range of therapeutics across the fields of oncology, cardiovascular disease and inflammatory diseases. More information on phenoxodiol and on the Novogen group of companies can be found at http://www.marshalledwardsinc.com and http://www.novogen.com . Under U.S. law, a new drug c...